Welcome to LookChem.com Sign In|Join Free

CAS

  • or
5-(BENZYLOXY)PENTANOIC ACID, also known as 5-(Phenylmethoxy)pentanoic Acid, is a chemical compound derived from δ-Valerolactone (V091445). It is commonly used in the synthesis of copolyesters through lipase-catalyzed ring-opening polymerization.

64740-39-2 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 64740-39-2 Structure
  • Basic information

    1. Product Name: 5-(BENZYLOXY)PENTANOIC ACID
    2. Synonyms: 5-(BENZYLOXY)PENTANOIC ACID;5-(BENZYLOXY)PENTANOIC ACID(WS203207)
    3. CAS NO:64740-39-2
    4. Molecular Formula: C12H16O3
    5. Molecular Weight: 208.25
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 64740-39-2.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 5-(BENZYLOXY)PENTANOIC ACID(CAS DataBase Reference)
    10. NIST Chemistry Reference: 5-(BENZYLOXY)PENTANOIC ACID(64740-39-2)
    11. EPA Substance Registry System: 5-(BENZYLOXY)PENTANOIC ACID(64740-39-2)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 64740-39-2(Hazardous Substances Data)

64740-39-2 Usage

Uses

Used in Polymer Industry:
5-(BENZYLOXY)PENTANOIC ACID is used as a monomer for the synthesis of copolyesters. It is utilized in lipase-catalyzed ring-opening polymerization to create biodegradable and environmentally friendly polymers with improved properties, such as enhanced mechanical strength and thermal stability.
Used in Pharmaceutical Industry:
5-(BENZYLOXY)PENTANOIC ACID is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications in treating various diseases and medical conditions.
Used in Cosmetic Industry:
5-(BENZYLOXY)PENTANOIC ACID is used as an active ingredient in cosmetic formulations. Its properties may contribute to the development of skincare and beauty products with improved efficacy, such as anti-aging, moisturizing, and skin brightening effects.
Used in Research and Development:
5-(BENZYLOXY)PENTANOIC ACID is used as a research compound for studying its chemical properties, reactivity, and potential applications in various fields. It serves as a valuable tool for scientists and researchers to explore new areas of chemistry and material science.

Check Digit Verification of cas no

The CAS Registry Mumber 64740-39-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,7,4 and 0 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 64740-39:
(7*6)+(6*4)+(5*7)+(4*4)+(3*0)+(2*3)+(1*9)=132
132 % 10 = 2
So 64740-39-2 is a valid CAS Registry Number.

64740-39-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-phenylmethoxypentanoic acid

1.2 Other means of identification

Product number -
Other names Pentanoic acid,5-(phenylmethoxy)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:64740-39-2 SDS

64740-39-2Relevant articles and documents

Discovery of Second Generation RORγ Inhibitors Composed of an Azole Scaffold

Kotoku, Masayuki,Maeba, Takaki,Fujioka, Shingo,Yokota, Masahiro,Seki, Noriyoshi,Ito, Keisuke,Suwa, Yoshihiro,Ikenogami, Taku,Hirata, Kazuyuki,Hase, Yasunori,Katsuda, Yoshiaki,Miyagawa, Naoki,Arita, Kojo,Asahina, Kota,Noguchi, Masato,Nomura, Akihiro,Doi, Satoki,Adachi, Tsuyoshi,Crowe, Paul,Tao, Haiyan,Thacher, Scott,Hashimoto, Hiromasa,Suzuki, Takayoshi,Shiozaki, Makoto

supporting information, p. 2837 - 2842 (2019/03/11)

Starting from a previously reported RORγ inhibitor (1), successive efforts to improve in vivo potency were continued. Introduction of metabolically beneficial motifs in conjunction with scaffold hopping was examined, resulting in discovery of the second generation RORγ inhibitor composed of a 4-(isoxazol-3-yl)butanoic acid scaffold (24). Compound 24 achieved a 10-fold improvement in in vivo potency in a mouse CD3 challenge model along with significant anti-inflammatory effects in a mouse dermatitis model.

18F-Labeled Derivatives of Irbesartan for Angiotensin II Receptor PET Imaging

Hoffmann, Matthias,Chen, Xinyu,Hirano, Mitsuru,Arimitsu, Kenji,Kimura, Hiroyuki,Higuchi, Takahiro,Decker, Michael

, p. 2546 - 2557 (2018/11/23)

The renin angiotensin aldosterone system (RAAS) is a hormonal cascade involved in the regulation of blood pressure and electrolyte balance, and represents a common target for the treatment of various diseases including hypertension, heart failure, and diabetes. Herein we present a novel 18F-labeled derivative of the drug irbesartan, one of the most prescribed angiotensin II type 1 receptor (AT1R) antagonists, for in vivo positron emission tomography (PET). This allows the in vivo measurement of AT1R expression, and thus the evaluation of functional changes in its expression under pathophysiological conditions. We followed various synthetic approaches optimized for the introduction of fluorine into different positions of the aliphatic side chain of irbesartan. Radioligand binding studies revealed that fluorine atoms at specified positions (α-position (IC50=6.6 nm) and δ-position (IC50=8.5 nm) of the aliphatic side chain) do not alter the binding properties of irbesartan (IC50=1.6 nm). After successful radiolabeling with fluorine-18 in a radiochemical yield of 11 %, we observed high renal uptake in healthy rats and pigs, which could be decreased by pretreatment with the parent compound irbesartan.

Total synthesis of s (+)-curcuphenol, s (+)-curcuquinone and s (+)-curcuhydroquinone

Chinta, Ramakoteswara Rao,Harikrishna,Tulam, Vijaya Kumar,Bejjanki, Naveen Kumar,Mainkar, Prathama S.,Dubey

, p. 771 - 778 (2016/03/01)

A synthesis of (-)-curcuphenol, (-)-curcuquinone and (-)-curcuhydroquinone from o-valerolactone is described. The key steps include an Evans asymmetric methylation of 5-(benzyloxy)pentanoic acid (5), an oxidative aromatization of enone (11) and a regioselective oxidation of the phenol to o-quinone derivative with bis(trifluoro acetate)iodobenzene.

Stereoselective α-Hydroxylation of Amides Using Oppolzer's Sultam as Chiral Auxiliary

Zhang, Lumin,Zhu, Lili,Yang, Jun,Luo, Jisheng,Hong, Ran

, p. 3890 - 3900 (2016/05/24)

An Oppolzer's sultam-based highly stereoselective α-hydroxylation of amides was developed to deliver the desired products in good yield and excellent diastereoselectivity (>20/1). The generally crystalline products and the recyclability of the chiral auxiliary illustrate the practicability and scalability of the current approach.

TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF

-

Paragraph 2913; 2914, (2016/06/06)

A compound represented by Formula [I]: or pharmaceutically acceptable salt thereof, wherein each symbol is as defined in the description.

A study of the reaction of n-BuLi with Ti(Oi-Pr)4 as a method to generate titanacyclopropane and titanacyclopropene species

Rassadin, Valentin A.,Six, Yvan

supporting information, p. 787 - 794 (2014/01/23)

The use of the combination of reagents Ti(Oi-Pr)4/n-BuLi, introduced by the group of J.J. Eisch in 2001, has only found a few applications so far, with sometimes conflicting observations. This article describes a study aimed at clarifying the nature, the stability and the reactivity of the active organometallic species involved. Reactions with CO2 and other trapping reagents reveal that it is generated within a few minutes at 0 C in THF, where it can be considered to be stable for 30 min. Most of our results are consistent with the expected titanacyclopropane nature of this reagent but some observations suggest that the chemistry at play may be more complicated.

Asymmetric radical addition of TEMPO to titanium enolates

Mabe, Phillip J.,Zakarian, Armen

supporting information, p. 516 - 519 (2014/04/03)

A mild method for a-hydroxylation of N-acyl oxazolidinones by asymmetric radical addition of the 2,2,6,6-tetramethylpiperidine N-oxy (TEMPO) radical to titanium enolates was developed. The high diastereoselectivity and broad scope of the reaction show synthetic utility for the a-hydroxylation of substrates that are not tolerant to strongly basic conditions.

Synthesis of the polyketide (E)-olefin of the jamaicamides

Watanabe, Satoshi,Watanabe, Sho,Aoki, Naoto,Usuki, Toyonobu

supporting information, p. 1397 - 1403 (2013/05/22)

The jamaicamides, isolated in Jamaica from the cyanobacterium Lyngbya majuscula, are new mixed polyketide-peptides that are known to be sodium channel blockers. The polyketide moiety contains an (E)-vinyl chloride, an undetermined methyl stereocenter (C9), and an (E)-olefin. Herein, we report the synthesis of the (E)-olefin moiety of the polyketide of the jamaicamides utilizing a Kocienski-Julia coupling. Supplemental materials are available for this article. Go to the publisher's online edition of Synthetic Communications to view the free supplemental file.

A simple method for asymmetric trifluoromethylation of N-acyl oxazolidinones via Ru-catalyzed radical addition to zirconium enolates

Herrmann, Aaron T.,Smith, Lindsay L.,Zakarian, Armen

supporting information; experimental part, p. 6976 - 6979 (2012/06/15)

A Ru-catalyzed direct thermal trifluoromethylation and perfluoroalkylation of N-acyloxazolidinones has been developed. The reaction is experimentally simple and requires inexpensive reagents while providing good yields of products with good levels of stereocontrol. Preliminary studies have shown notable compatibility with functional groups, aromatics, and certain heteroaromatic substituents. The described method provides a useful alternative for the synthesis of fluorinated materials in an experimentally convenient manner.

AMIDE COMPOUND AND MEDICINAL USE THEREOF

-

Page/Page column 72, (2013/02/27)

A compound of formula [I-W]: wherein each symbol is as defined in the description, or a pharmaceutically acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 64740-39-2